Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Non-Current Deferred Tax Liability: 2017-2022

Historic Non-Current Deferred Tax Liability for Aclaris Therapeutics (ACRS) over the last 6 years, with Dec 2022 value amounting to $367,000.

  • Aclaris Therapeutics' Non-Current Deferred Tax Liability changed negligibly% to $367,000 in Q3 2023 from the same period last year, while for Sep 2023 it was $367,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $367,000 for FY2022, which is negligibly% changed negligibly from last year.
  • As of FY2022, Aclaris Therapeutics' Non-Current Deferred Tax Liability stood at $367,000, which was down 0.00% from $367,000 recorded in FY2021.
  • Aclaris Therapeutics' Non-Current Deferred Tax Liability's 5-year high stood at $549,000 during FY2018, with a 5-year trough of $367,000 in FY2020.
  • Over the past 3 years, Aclaris Therapeutics' median Non-Current Deferred Tax Liability value was $367,000 (recorded in 2022), while the average stood at $367,000.
  • Data for Aclaris Therapeutics' Non-Current Deferred Tax Liability shows a maximum YoY tumbled of 33.15% (in 2020) over the last 5 years.
  • Over the past 5 years, Aclaris Therapeutics' Non-Current Deferred Tax Liability (Yearly) stood at $549,000 in 2018, then remained steady at $549,000 in 2019, then tumbled by 33.15% to $367,000 in 2020, then remained steady at $367,000 in 2021, then remained steady at $367,000 in 2022.